Skip to main content
. 2024 Oct 16;14:24253. doi: 10.1038/s41598-024-75595-8

Table 1.

Demographics and past psychedelic use.

Demographic information M SD Min Max n %
Age 32.25 10.20 19.00 74.00
Male 362 58.00
Female 262 42.00
Other 5 8.00
Education level
 Lower Secondary education 10 1.59
 Upper Secondary or Vocational education 201 31.96
 University: Bachelor’s degree 292 46.42
 University: Master’s degree 120 19.08
 University: Doctoral degree 6 0.95
 Income level [1–5] 2.77 0.89 1.00 5.00
Past psychedelic use
 Cumulative frequency 7.70 26.72 1.00 500.00
 Time since last use (years) 2.93 5.48 0.00 45.83
 Time since most meaningful experience (years) 2.22 3.50 0.00 25.00
Average frequency of use
 Once every four years or less often 290 46.10
 Once every three years 31 4.93
 Once every two years 70 11.13
 Once a year 81 12.88
 Few times a year 128 20.35
 Monthly 21 3.34
 Weekly 6 0.95
 Daily 2 0.32
 Average dose [1–3] 1.42 0.58 1.00 3.00
Experience facilitated by
 LSD 293 47.00
 Psilocybin 339 54.00
 DMT 40 6.00
 5-MeO-DMT 4 0.60
 Mescaline 20 3.00
Most frequently reported setting
 Home or home-like environment 440 70.00
 Nature 56 9.00
 Public gathering (e.g., a festival) 56 9.00
Most frequently reported intention
 To relax and enjoy 377 60.00
 Curiosity 327 52.00
 Spiritual 63 10.00
 Therapeutic 44 7.00
Most frequently reported country of origin
 South Africa 150 24.00
 UK 111 18.00
 Poland 74 12.00
 Portugal 53 8.5
 Other 236 37.5

The average dose was estimated on an ordinal scale from 1 to 3 (1 = Small; 2 = Medium; 3 = Strong) with a “Don’t know” option included. Examples of typical doses of commonly used substances were given. LSD Lysergic acid diethylamide, DMT Dimethyltryptamine, 5-MeO-DMT 5-methoxy-N, N-dimethyltryptamine.